SPRO vs. SPRX

In the year-to-date period, SPRO achieves a 142.72% return, which is significantly higher than SPRX's -2.21% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Spero Therapeutics, Inc. (SPRO) and Spear Alpha ETF (SPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current SPRO Sharpe Ratio is 0.30, which is comparable to the SPRX Sharpe Ratio of 0.40. The chart below compares the historical Sharpe Ratios of SPRO and SPRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither SPRO nor SPRX has paid dividends to shareholders.

The maximum SPRO drawdown since its inception was -97.46%, which is greater than SPRX's maximum drawdown of -51.22%. Use the drawdown chart below to compare losses from any high point for SPRO and SPRX.

Spero Therapeutics, Inc. (SPRO) has a higher volatility of 126.14% compared to Spear Alpha ETF (SPRX) at 10.69%. This indicates that SPRO's price experiences larger fluctuations and is considered to be riskier than SPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.